BridgeMD
New treatment option for Respiratory Morbidity
Official title Low Dose Antenatal Corticosteroids for Late Preterm Delivery
ClinicalTrials.gov ID: NCT05698966
What this study is testing
- What it's testing
- This is a study proposal for a clinical trial to evaluate the effectiveness of a reduced dose of antenatal betamethasone (a steroid medication) in preventing respiratory problems in late preterm infants (born between 34 and 36 weeks of gestation). The study will be conducted in medical centers in Israel and will involve women who are at high risk for delivering a late preterm infant.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- - Singleton pregnancy at 34 weeks 0 days to 36 weeks 5 days of gestation at risk for / high probability of delivery in the late preterm period...
- Preterm uterine contractions with intact membranes, and at least 3 cm dilation or 75% cervical effacement
- Spontaneous rupture of the membranes
- Expected preterm delivery for any other indication via induction or cesarean between 24 hours to 7 days after the planned randomization, as...
You likely can't join if
- They had already received a full course of betamethasone.
- Expected delivery in less than 12 hours, irrespective of cause including: 1)ruptured membranes in the presence of more than 6 contractions per hour...
- Prior ACS treatment
- Current known or suspected infection ( viral, bacterial or other)
- Pre-gestational diabetes mellitus.
- Any infection that required antibiotics or hospitalization in the month prior to study allocation - Poor understanding of the inform consent language
The study team makes the final eligibility decision.
Where it's taking place
- Afula, Israel
- Ashkelon, Israel
- Beersheba, Israel
- Hadera, Israel
- Haifa, Israel
- Jerusalem, Israel
- Kfar Saba, Israel
- Nahariya, Israel
- Petah Tikva, Israel
- Ramat Gan, Israel
- Safed, Israel
- Tel Aviv, Israel
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Afula, Israel; Ashkelon, Israel; Beersheba, Israel; Hadera, Israel; Haifa, Israel; Jerusalem, Israel and 6 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.